These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. UK developments. Kreuzer M Med Device Technol; 2003 Dec; 14(10):38-9. PubMed ID: 14981893 [TBL] [Abstract][Full Text] [Related]
28. Mandated coverage: labor activity. Ignagni K Rep Natl Forum Hosp Health Aff; 1991; ():76-9; discussion 79-81, 100-7. PubMed ID: 10120222 [No Abstract] [Full Text] [Related]
29. Who speaks for the health consumer? Fox MH J Health Care Poor Underserved; 2008 Aug; 19(3):671-6. PubMed ID: 18677063 [TBL] [Abstract][Full Text] [Related]
30. Industrial biotechnology - past, present and future. Wohlgemuth R N Biotechnol; 2012 Jan; 29(2):165. PubMed ID: 22154940 [No Abstract] [Full Text] [Related]
31. Price trend analysis and its implications for the development of new medical technologies. Brown A; Meenan BJ; Young TP Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5156-9. PubMed ID: 18003168 [TBL] [Abstract][Full Text] [Related]
32. Industry involvement in Australian agrobiotechnology: the views of scientists. Lawrence G; Norton J Australas Biotechnol; 1994; 4(6):362-8. PubMed ID: 7765829 [TBL] [Abstract][Full Text] [Related]
33. The emergence of Texas biotech. Richardson M Tex Med; 1994 Apr; 90(4):31-5. PubMed ID: 8009464 [No Abstract] [Full Text] [Related]
34. Telecommunications. Hospitals explore new electronic links to reduce costs, increase access. Lumsdon K Hospitals; 1992 Sep; 66(18):46, 48, 50-2. PubMed ID: 1516920 [No Abstract] [Full Text] [Related]
36. The US biotechnology industry: an analysis of trends. Dibner MD Aust J Biotechnol; 1988 Sep; 2(2):129-32. PubMed ID: 2485326 [No Abstract] [Full Text] [Related]
37. Changing patent strategies: what will they mean for the industry? Mills AE; Tereskerz PM Nat Biotechnol; 2007 Aug; 25(8):867-8. PubMed ID: 17687359 [No Abstract] [Full Text] [Related]
38. Perspective: Why communication in biotechnology is important. Gassen HG Biotechnol J; 2007 Sep; 2(9):1051-2. PubMed ID: 17768767 [No Abstract] [Full Text] [Related]
39. Metagenomics: an inexhaustible access to nature's diversity. Langer M; Gabor EM; Liebeton K; Meurer G; Niehaus F; Schulze R; Eck J; Lorenz P Biotechnol J; 2006; 1(7-8):815-21. PubMed ID: 16897828 [TBL] [Abstract][Full Text] [Related]
40. Designs that enrich lives. Link A; Stark H Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]